Patents Examined by Bradley L. Sisson
  • Patent number: 11407991
    Abstract: Methods for extracting high quality nucleic acids from a heterogenous collection of nucleic acid-containing materials from a biological sample are disclosed. The heterogenous collection of nucleic-acid containing materials may contain cells or microvesicles, or both. The extractions obtained by the methods described herein are characterized by high yield and high integrity, making the extracted nucleic acids useful for various applications in which high quality nucleic acid extractions are preferred, e.g., a diagnosis, prognosis, or therapy evaluation for a medical condition.
    Type: Grant
    Filed: April 26, 2016
    Date of Patent: August 9, 2022
    Assignee: Exosome Diagnostics, Inc.
    Inventors: Wayne Comper, Leileata M. Russo, Johan Karl Olov Skog
  • Patent number: 11396672
    Abstract: The current disclosure relates to methods, compositions and kits for detecting modified adenosine in a target RNA molecule. Aspects relate to a method for detecting modified adenosine in a target ribonucleic acid (RNA) comprising contacting the target RNA with an adenosine deaminase enzyme (adenosine deaminase, RNA-specific) to generate a target RNA with deaminated adenosines and sequencing the target RNA with deaminated adenosines; wherein the modified adenosine is detected when the nucleotide sequence is adenosine.
    Type: Grant
    Filed: August 30, 2016
    Date of Patent: July 26, 2022
    Assignee: The University of Chicago
    Inventors: Chuan He, Kai Chen, Qing Dai
  • Patent number: 11390907
    Abstract: Provided herein is a method for making a pool of probes by primer extension. In certain embodiments, the method comprises hybridizing a first population of oligonucleotides comprising a top strand sequence having the following formula V1-B-3? with a second population of oligonucleotides comprising a bottom strand sequence having the following formula V2?-B?-3? to provide a population of duplexes. After hybridizing, the 3? ends of the oligonucleotides in the duplexes are extended to produce a population of double stranded products comprising a top strand sequence having the following formula V1-B-V2, where V2 is complementary to V2?.
    Type: Grant
    Filed: March 5, 2013
    Date of Patent: July 19, 2022
    Assignee: Agilent Technologies, Inc.
    Inventors: Michael Ruvolo, Emily Marine Leproust
  • Patent number: 11390902
    Abstract: Methods and reagent for determining the presence and/or for quantifying the amount of a target nucleic acid sequences in a sample are provided. In some aspects, the methods comprise performing a melt analysis by detecting, a signal from a probe at a temperature that is lower than the Tm of the probe and a signal at a temperature that is higher than the Tm of the probe, without detecting a signal at the Tm of the probe.
    Type: Grant
    Filed: January 22, 2019
    Date of Patent: July 19, 2022
    Assignee: LUMINEX CORPORATION
    Inventors: Douglas Whitman, Jennifer Bernier, William Wang
  • Patent number: 11390909
    Abstract: The present invention relates to methods for the detection of nucleic acids of defined sequence, and compositions and kits for use in said methods. The methods employ nicking agent(s) and a sequential series of oligonucleotide probes to produce probe fragments in the presence of a target nucleic acid.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: July 19, 2022
    Assignee: Sense Biodetection Limited
    Inventors: Henry John Lamble, Christopher Egan, David Lloyd, Eryk Dunski
  • Patent number: 11390914
    Abstract: The disclosure provides for methods, compositions, systems, devices, and kits for whole transcriptome amplification using stochastic barcodes.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: July 19, 2022
    Assignee: Becton, Dickinson and Company
    Inventors: Glenn Fu, Craig Betts, Christina Fan, Gretchen Yinbon Lam
  • Patent number: 11384382
    Abstract: Methods of preparing double-stranded nucleic acids with single-stranded overhangs for amplification and sequencing are disclosed. Contacting a blunt-ended double-stranded nucleic acid molecules with Taq results in non-templated directed addition of a single nucleotide to the 3? ends of the nucleic acid with A added most frequently followed by G followed by C and T. G tailing is sufficiently frequent that the efficiency of ligation of nucleic acid molecules to adapters can be significantly increased by including adapters tailed with T and C. The ligation efficiency can be increased even further with blunted-ended adapters to ligate to blunt-ended nucleic acid molecules that failed to undergo tailing.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: July 12, 2022
    Inventors: Andrew Kennedy, Stefanie Ann Ward Mortimer
  • Patent number: 11384376
    Abstract: The present invention relates to compositions and methods (reagents and protocols) for the post-synthetic modification of nucleic acids obtained from solid-phase oligonucleotide synthesis with a label (such as fluorescent dyes). The coupling reagent is the triazine-based salt 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium (DMT-MM) in the presence of a counteranion.
    Type: Grant
    Filed: May 28, 2019
    Date of Patent: July 12, 2022
    Assignee: Roche Molecular Systems, Inc.
    Inventor: Alexander Nierth
  • Patent number: 11377682
    Abstract: The disclosure provides compositions and methods for amplifying and/or analyzing nucleic acids.
    Type: Grant
    Filed: May 17, 2017
    Date of Patent: July 5, 2022
    Assignee: Ampliwise Inc.
    Inventors: Kai Wu, Mindy Su, Xing Su
  • Patent number: 11352658
    Abstract: The present invention relates to a method for selecting a target region of interest (ROI) in a target nucleic acid molecule using a nucleic acid probe comprising a 3? sequence capable of hybridising to a target nucleic acid molecule and acting as a primer for the production of a complement of the target ROI (i.e. by target templated extension of the primer), and a sequence capable of templating the circularisation and ligation of the extended probe comprising the reverse complement of the target ROI and a portion of the probe. The circularised molecule thus obtained contains the reverse complement of the target ROI and may be subjected to further analysis and/or amplification etc. The probe may be provided as an oligonucleotide comprising a stem-loop structure or as a partially double-stranded construct and comprises a single-stranded 3? end region containing the target-binding site.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: June 7, 2022
    Assignee: NAVINCI DIAGNOSTICS AB
    Inventors: Ulf Landegren, Rachel Yuan Nong
  • Patent number: 11344121
    Abstract: The subject invention pertains to biomarkers for identifying a subject as having high risk of the development PE. The biomarkers presented herein include miRNAs, post-translational modification of histone proteins, amount, expression and/or activity of histone or DNA modifying enzymes and methylation of sites in the genomic DNA. In certain embodiments, increased miR-17, increased acetylation of H4 histone protein, decreased amount, expression and/or activity of HDACS mRNA or protein or increased methylation of DNA at the genomic site CYP19A1 in the blood, serum or plasma of a subject compared to that of a control subject is used to predict the development of PE in the subject. The invention also provides kits and reagents to conduct assays to quantify biomarkers described herein. The invention further provides the methods of treating and/or managing PE in a subject identified as having a high risk of the development of PE.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: May 31, 2022
    Assignee: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventor: Mahua Choudhury
  • Patent number: 11312991
    Abstract: The present invention provides an analysis method by which a DNA element can be identified with higher sensitivity, and a transcription amount of the DNA element can be determined.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: April 26, 2022
    Assignee: KABUSHIKI KAISHA DNAFORM
    Inventors: Yasuhiro Murakawa, Yujiro Takegami
  • Patent number: 11274341
    Abstract: Assay methods for preparing a biomolecule analyte includes hybridizing a sequence specific oligonucleotide probe to a biomolecule template and reacting the resulting analyte with a binding moiety.
    Type: Grant
    Filed: February 10, 2012
    Date of Patent: March 15, 2022
    Assignee: NABsys, 2.0 LLC
    Inventor: John S. Oliver
  • Patent number: 11214826
    Abstract: The invention provides a method of karyotyping (for example for the detection of trisomy) a target cell to detect chromosomal imbalance therein, the method comprising: (a) interrogating closely adjacent biallelic SNPs across the chromosome of the target cell (b) comparing the result at (a) with the SNP haplotype of paternal and maternal chromosomes to assemble a notional haplotype of target cell chromosomes of paternal origin and of maternal origin (c) assessing the notional SNP haplotype of target cell chromosomes of paternal origin and of maternal origin to detect aneuploidy of the chromosome in the target cell. Also provided are related computer-implemented embodiments and systems.
    Type: Grant
    Filed: November 13, 2006
    Date of Patent: January 4, 2022
    Inventor: Alan Handyside
  • Patent number: 11142544
    Abstract: A novel substrate-bound DNAzyme complex is provided comprising a DNAzyme bound to a nucleic acid-based substrate. The DNAzyme comprises a pair of binding arms which hybridize to binding regions on the substrate, and a catalytic domain between the binding arms. The nucleic acid-based substrate comprises a phosphorothioate-modified ribonucleotide cleavage site between the binding regions of the substrate. The catalytic domain of the DNAzyme catalyzes heavy metal-dependent cleavage of the substrate cleavage site. The DNAzyme complex is useful in a method of heavy metal sensing. A novel cadmium-selective DNAzyme is also described for cadmium sensing.
    Type: Grant
    Filed: April 28, 2015
    Date of Patent: October 12, 2021
    Inventors: Juewen Liu, Po-Jung Jimmy Huang
  • Patent number: 11111534
    Abstract: Provided are methods of nucleic acid sample preparation for analysis, including analysis using nanopore sequencing applications. In particular provided are methods that allow for the creation of circular and linear DNA samples that contain asymmetric ends to ligate different and desired adaptors to the end of the sample, methods to create single nucleic acid molecules that automatically form concatemers for higher sequencing throughput; methods to create multiple copies (temperature dependent, multi-primed, open-fold replication) of one original nucleic acid sample, or to create single nucleic acid molecules containing multiple copies of more than one original nucleic acid sample (concatemerized samples) for improved accuracy and throughput are described; and methods for improved modified base calling.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: September 7, 2021
    Assignee: Roche Sequencing Solutions, inc.
    Inventors: Randall Davis, Michael Dorwart, Janine Mok
  • Patent number: 11104936
    Abstract: The present disclosure describes the thermodynamic design and concentrations necessary to design probe compositions with desired optimal specificity that enable enrichment, detection, quantitation, purification, imaging, and amplification of rare-allele-bearing species of nucleic acids (prevalence <1%) in a large stoichiometric excess of a dominant-allele-bearing species (wildtype). Being an enzyme-free and homogeneous nucleic acid enrichment composition, this technology is broadly compatible with nearly all nucleic acid-based biotechnology, including plate reader and fluorimeter readout of nucleic acids, microarrays, PCR and other enzymatic amplification reactions, fluorescence barcoding, nanoparticle-based purification and quantitation, and in situ hybridization imaging technologies.
    Type: Grant
    Filed: October 17, 2016
    Date of Patent: August 31, 2021
    Assignee: William Marsh Rice University
    Inventors: David Yu Zhang, Juexiao Wang
  • Patent number: 11078528
    Abstract: The invention relates to methods of in situ detection of a nucleic acid variation of a target nucleic acid in a sample, including single nucleotide variations, multi-nucleotide variations or splice sites. The method can comprise the steps of contacting the sample with a probe that detects the nucleic acid variation or splice site and a neighbor probe; contacting the sample with pre-amplifiers that bind to the nucleic acid variation probe or splice site probe and neighbor probe, respectively; contacting the sample with a collaboration amplifier that binds to the pre-amplifiers; and contacting the sample with a label probe system, wherein hybridization of the components forms a signal generating complex (SGC) comprising a target nucleic acid with the nucleic acid variation or splice site, the probes and amplifiers; and detecting in situ signal from the SGC on the sample.
    Type: Grant
    Filed: October 11, 2016
    Date of Patent: August 3, 2021
    Assignee: ADVANCED CELL DIAGNOSTICS, INC.
    Inventors: Yuling Luo, Xingyong Wu, Liuliu Pan, Xiaoming Wang, Xiao-Jun Ma, Nan Su, Steve Chen
  • Patent number: 11060134
    Abstract: Disclosed is a cell selection method including a sample preparation step of preparing a sample by performing staining of nucleic acid in each of cells by a first fluorescent dye; and hybridization with respect to an evaluation target region in DNA in each cell by an evaluation probe including a second fluorescent dye; a light receiving step of applying light to the sample and receiving fluorescence from the first fluorescent dye and fluorescence from the second fluorescent dye; and a selection step of selecting an analysis target cell on the basis of intensity of the fluorescence from the first fluorescent dye and intensity of the fluorescence from the second fluorescent dye, wherein the first fluorescent dye is a dye that emits fluorescence having a first wavelength, and the second fluorescent dye is a dye that emits fluorescence having a second wavelength different from the first wavelength.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: July 13, 2021
    Assignee: SYSMEX CORPORATION
    Inventors: Yusuke Takahashi, Masatoshi Yanagida
  • Patent number: 11034995
    Abstract: The present invention provides a method for detecting an analyte in a sample, said method comprising a) contacting said sample with a set of proximity probes comprising at least first and second proximity probes, which probes each comprise an analyte-binding domain capable of binding directly or indirectly to said analyte and a nucleic acid domain, such that the proximity probes can simultaneously bind, directly or indirectly, to the analyte, wherein i) the nucleic acid domains of said first and second proximity probes comprise regions capable of mediating an interaction involving said domains when under permissive conditions; and ii) the nucleic acid domain of one of said first and second probes comprises an HCR initiator region comprised within a metastable secondary structure such that it is unable to initiate an HCR reaction until released from said metastable secondary structure; b) introducing permissive conditions to allow the nucleic acid domains of said first and second probes to interact with each o
    Type: Grant
    Filed: February 4, 2015
    Date of Patent: June 15, 2021
    Assignee: NAVINCI DIAGNOSTICS AB
    Inventors: Ola Söderberg, Björn Koos, Cosimo Ducani, Björn Högberg